Literature DB >> 30267869

Prebiotics and Probiotics in Digestive Health.

Eamonn M M Quigley1.   

Abstract

As the importance of the gut microbiota in health and disease is increasingly recognized interest in interventions that can modulate the microbiota and its interactions with its host has soared. Apart from diet, prebiotics and probiotics represent the most commonly used substances taken in an effort to sustain a healthy microbiome or restore balance when it is believed bacterial homeostasis has been disturbed in disease. While a considerable volume of basic science attests to the ability of various prebiotic molecules and probiotic strains to beneficially influence host immune responses, metabolic processes and neuro-endocrine pathways, the evidence base from human studies leaves much to be desired. This translational gap owes much to the manner in which this sector is regulated but also speaks to the challenges that confront the investigator who seeks to explore microbiota modulation in either healthy populations or those who suffer from common digestive ailments. For many products marketed as probiotics, some of the most fundamental issues relating to quality control, such as characterization, formulation, viability safety are scarcely addressed.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Microbiota; Prebiotic; Probiotic; Synbiotics

Mesh:

Substances:

Year:  2018        PMID: 30267869     DOI: 10.1016/j.cgh.2018.09.028

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  47 in total

1.  Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.

Authors:  Suzanne R Sharpton; Bharat Maraj; Emily Harding-Theobald; Eric Vittinghoff; Norah A Terrault
Journal:  Am J Clin Nutr       Date:  2019-07-01       Impact factor: 7.045

Review 2.  Nutraceuticals as modulators of gut microbiota: Role in therapy.

Authors:  Eamonn M M Quigley
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

3.  Comparative effect of dietary supplements on the performance and severity of experimental Eimeria tenella infection in broiler chickens.

Authors:  Matthew Ogwiji; Isa Danladi Jatau; Joseph Audu Natala; Dahiru Sani; Buhari Habibu; Aliyu Danlami Andamin; Stephen Kyari; Khadijat Abidemi Gasaliyu
Journal:  Trop Anim Health Prod       Date:  2022-05-27       Impact factor: 1.559

4.  Tailoring fructooligosaccharides composition with engineered Zymomonas mobilis ZM4.

Authors:  Adelaide Braga; Daniela Gomes; João Rainha; Beatriz B Cardoso; Cláudia Amorim; Sara C Silvério; María Fernández-Lobato; Joana L Rodrigues; Lígia R Rodrigues
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-24       Impact factor: 4.813

5.  Chitosan alleviated menopausal symptoms and modulated the gut microbiota in estrogen-deficient rats.

Authors:  Xuangao Wu; Min Jung Kim; Hye Jeong Yang; Sunmin Park
Journal:  Eur J Nutr       Date:  2020-09-10       Impact factor: 5.614

6.  Yogurt consumption and colorectal cancer incidence and mortality in the Nurses' Health Study and the Health Professionals Follow-Up Study.

Authors:  Karin B Michels; Walter C Willett; Rita Vaidya; Xuehong Zhang; Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2020-12-10       Impact factor: 7.045

Review 7.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

8.  Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey.

Authors:  Vikram Rangan; Sarah Ballou; Andrea Shin; Michael Camilleri; Anthony Lembo
Journal:  Gastroenterology       Date:  2019-11-09       Impact factor: 22.682

9.  Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both In Vitro and In Vivo Conditions.

Authors:  Matěj Hrala; Juraj Bosák; Lenka Micenková; Jitka Křenová; Matej Lexa; Viktória Pirková; Zuzana Tomáštíková; Ivana Koláčková; David Šmajs
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

10.  Probiotic potential of Weissella paramesenteroides MYPS5.1 isolated from customary dairy products and its therapeutic application.

Authors:  Monika Yadav; Pratyoosh Shukla
Journal:  3 Biotech       Date:  2021-12-07       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.